A NOVEL LIKELY PATHOGENIC VARIANT
IN THE RUNX1 GENE AS THE CAUSE
OF CONGENITAL THROMBOCYTOPENIA
Despotović M1,*, Pereza N2, Peterlin B3, Ostojić S2, Golob B3, Maver A3, Roganović J4
*Corresponding Author: Marta Despotović, University of Rijeka, Faculty of Medicine, Braće Branchetta
20, 51000 Rijeka, Croatia. Tel: +385-91-732-6486. E-mail: despotovicmarta@gmail.com
page: 4
|
|
REFERENCES
1. Almazni I, Stapley R, Morgan N, Inherited Thrombocytopenia:
Update on Genes and Genetic Variants
Which may be Associated With Bleeding, Front Cardiovasc
Med. 2019; 6: 80.
2. Luddy RE, Champion LA, Schwartz AD. A fatal myeloproliferative
syndrome in a family with thrombocytopenia
and platelet dysfunction. Cancer. 1978; 41:
1959-63.
3. Galera P, Dulau-Florea A, Calvo KR. Inherited
thrombocytopenia and platelet disorders with germline
predisposition to myeloid neoplasia. Int J Lab
Hematol. 2019; 41(Suppl. 1): 131– 141.
4. Luo X, Feurstein S, Mohan S, Porter CC, Jackson SA,
Keel S, et al. ClinGen Myeloid Malignancy Variant
Curation Expert Panel recommendations for germline
RUNX1 variants. Blood Adv. 2019 Oct 22; 3(20):
2962-2979.
5. Tsai SC, Shih LY, Liang ST, Huang YJ, Kuo MC,
Huang CF, et al. Biological Activities of RUNX1
Mutants Predict Secondary Acute Leukemia Transformation
from Chronic Myelomonocytic Leukemia
and Myelodysplastic Syndromes. Clin Cancer Res.
2015 Aug 1; 21(15): 3541-51.
6. Harada H, Harada Y, Niimi H, Kyo T, Kimura A,
Inaba T. High incidence of somatic mutations in the
AML1/RUNX1 gene in myelodysplastic syndrome
and low blast percentage myeloid leukemia with myelodysplasia.
Blood. 2004 Mar 15; 103(6): 2316-24.
7. Tang JL, Hou HA, Chen CY, Liu CY, Chou WC,
Tseng MH, et al. AML1/RUNX1 mutations in 470
adult patients with de novo acute myeloid leukemia:
prognostic implication and interaction with other gene
alterations. Blood. 2009 Dec 17; 114(26): 5352-61.
8. Deuitch N, Broadbridge E, Cunningham L, et al.
RUNX1 Familial Platelet Disorder with Associated
Myeloid Malignancies. 2021 Mar 4 [Updated 2021
May 6]. In: Adam MP, Ardinger HH, Pagon RA, et
al., editors. GeneReviews® [Internet]. Seattle (WA):
University of Washington, Seattle; 1993-2022.
|
|
|
|
 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
